M&I Faculty Receive Multiple Awards in 2018

M&I Endowed Chair Professor Yousef Abu-Kwaik was recently awarded a National Institute of Health R01 grant entitled "Innate immunity and inflammatory response of macrophages to Legionella infection".  The grant received a score of 1%.  This NIH funded project is budgeted from 09/14/2018 - 08/31/2023 for $1,913,286.

M&I Associate Professor Esma Yolcu recently received a SBIR Phase I award from the National Institute of Health entitled “Exploiting activation-induced cell death as a means of inducing tolerance to kidney allografts”.  The award is a collaboration with the University of Wisconsin, Madison.

M&I Associate Professor Esma Yolcu and M&I Professor Haval Shirwan recently received a $500,000 gift in memory of William Marvin Petty, MD.  The funds are to be used to advance Type 1 Diabetes research conducted in the School of Medicine Department of Microbiology and Immunology.  Dr. Yolcu and Dr. Shirwan’s research focuses on the use of ProtEx technology, pioneered by the team, as an alternative to gene therapy for immunomodulation to treat transplant rejection and autoimmune diseases with particular focus on Type 1 Diabetes.     


M&I Professor Haval Shirwan received a five year NIH/NIAID R01 grant award in support of the application entitled “A novel immunomodulatory approach to overcome innate and adaptive immune barriers to islet transplantation”.  The project is for the period  11/5/2018 – 10/31/2023 with a total budget of $1,943,360.


M&I Associate Professor Bing Li was recently awarded a National Institute of Health R01 grant entitled "Immunomodulatory mechanisms of E-FABP in psoriasis pathogenesis".  This NIH funded project is budgeted from 09/24/2018 - 08/31/2023 for $1,925,000.


M&I Associate Professor's Matthew Lawrenz (PI) and Jonathan Warawa (Co-PI) were awarded a contract from the FDA entitled “Development of a Mouse Model for Preclinical Screening of Investigational Drugs Against Pseudomonas Aeruginosa and Acinetobacter Baumannii”.  The $933,606 award runs from 9/19/2018 to 9/18/2020. http://www.uoflnews.com/post/uofltoday/uofl-researchers-escalate-efforts-against-multi-drug-resistant-bacteria-with-fda-contract/



Dr. Abu-Kwaik


Dr. Shirwan


Dr. Yolcu

Bing Li

Dr. Li

Matthew Lawrenz

Dr. Lawrenz

Jonathan Warawa

Dr. Warawa